Products
Platform
Research
Market
Learn
Compare Mutual Funds
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Select a Mutual Fund
Fund Details
Risk | Very High | - |
Rating | - | - |
Min SIP Amount | - | - |
Expense Ratio | 1.41 | - |
NAV | ₹28.72 | - |
Fund Started | 29 Mar 2017 | - |
Fund Size | ₹30.14 Cr | - |
Exit Load | - | - |
Risk
Very High
-
Rating
-
-
Min SIP Amount
-
-
Expense Ratio
1.41
-
NAV
₹28.72
-
Fund Started
29 Mar 2017
-
Fund Size
₹30.14 Cr
-
Exit Load
-
-
Returns
1 Year | 2.28% | - |
3 Year | 19.24% | - |
5 Year | 31.33% | - |
1 Year
2.28%
-
3 Year
19.24%
-
5 Year
31.33%
-
Holding Analysis
Equity | 95.33% | - |
Cash | 4.67% | - |
Equity
95.33%
-
Cash
4.67%
-
Top Holdings
Top 10 Holdings |
| - |
Top 10 Holdings
Name | Assets |
|---|---|
Aster DM Healthcare Ltd. | 5.97% |
Affle 3I Ltd. | 5.68% |
Safari Industries (India) Ltd. | 4.83% |
Sapphire Foods India Ltd. | 4.19% |
KSB Ltd. | 4.18% |
CSB Bank Ltd. | 3.83% |
Multi Commodity Exchange Of India Ltd. | 3.73% |
Ujjivan Small Finance Bank Ltd. | 3.71% |
Greenpanel Industries Ltd. | 3.54% |
Procter & Gamble Health Ltd. | 3.29% |
-
Fund Manager
Name | Dwijendra Srivastava | - |
Start Date | 02 Jul 2025 | - |
Name
Dwijendra Srivastava
-
Start Date
02 Jul 2025
-
About Fund
Description | The scheme seeks to generate capital appreciation over a period of ten years by predominantly investing in equity and equity-related instruments of companies that can be termed as micro-cap and from income tax benefit available. | - |
Launch Date | 29 Mar 2017 | - |
Description
The scheme seeks to generate capital appreciation over a period of ten years by predominantly investing in equity and equity-related instruments of companies that can be termed as micro-cap and from income tax benefit available.
-
Launch Date
29 Mar 2017
-